Skip to main content

Bio-Rad, Luminex to Commercialize Protein System

NEW YORK, Dec 12 - Bio-Rad Laboratories and Luminex said Tuesday they had entered into an agreement to jointly commercialize a system for drug discovery applications based on Luminex's LabMAP technology.

Bio-Rad has incorporated Luminex's microsphere-based assay technology and reader into its Bio-Plex Protein Array System. The new product, which will be available in the first quarter of 2001, is the outcome of a two-year collaboration between the companies.

Financial terms of the deal and the collaborative marketing arrangement were not disclosed.

The system, which combines a Luminex analyzer, Bio-Rad’s software, and reagent kits, is designed to help researchers in the life sciences market to easily extract more data from small samples.

Luminex's system is designed to perform up to 100 assays simultaneously on a single drop of fluid, with the capability for both medium- and high-throughput assay applications.

" The hallmark of Bio-Rad Laboratories' integrated Bio-Plex system is that it comes equipped with distinctive improvements in application software and optimized assay kit formulation," Norman Schwartz, vice president of Bio-Rad's life science group, said in a statement.

" These features significantly increase the utility and ease-of-use for researchers and broaden the appeal of the extremely powerful Luminex platform," he said.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.